GLP-1 Black Friday Scams: Red Flags in "Research Peptide" and No-Prescription Offers

The riskiest GLP-1 "deals" this Black Friday will not look like scams. They will look like sales. The real warning signs are an offer with no prescription, a vial labeled "research use only" or "not for human consumption," no named U.S. pharmacy, and a semaglutide salt form. A legitimate discount still comes with a licensed provider and a state-licensed pharmacy.

• Every GLP-1 medicine sold in the U.S. needs a prescription.
• The FDA has warned companies selling semaglutide and tirzepatide labeled "research use only" with dosing instructions, and urges people not to buy them.
• The FDA says salt forms such as semaglutide sodium or acetate are different active ingredients.
• The FDA says counterfeit GLP-1 pens are being sold in the U.S..
• The FTC warns about fake news-style ads, seller-written reviews and "free" trials that are not free.
• Report suspected fraud at ReportFraud.ftc.gov and bad reactions to FDA MedWatch.

Why scams spike around Black Friday

Black Friday trains all of us to move fast. Countdown clocks, "today only" banners and deep percentage discounts are normal for TVs and sweaters. Scammers know that, and GLP-1 medicines are some of the most searched health products in the country.

That combination is the risk. A real program may run a holiday discount. A risky seller can copy the same look, the same "% off" badge and the same before-and-after photos, then skip every safety step behind the scenes. The page design will not tell you which is which. The questions in this guide will.

"Research use only" GLP-1s

This is the biggest red flag for this holiday season. Some websites sell semaglutide, tirzepatide and similar compounds as "research peptides," labeled "for research use only" or "not for human consumption." Then they include dosing charts, mixing guides or customer reviews about weight loss.

The FDA has sent warning letters to companies doing exactly this. It says these products have been sold directly to consumers for human use with dosing instructions, and it urges people not to buy them because their quality is unknown and they may be harmful.

Watch for the softer versions too: "lab grade," "for laboratory use," "peptide supply," or a disclaimer at the bottom of an otherwise normal-looking weight-loss page.

No-prescription offers

GLP-1 medicines are prescription-only in the U.S. A seller that lets you check out without answering health questions, without a provider and without a prescription is not a shortcut. It is the FDA's first warning sign of an unsafe online pharmacy.

Skipping the provider is not just a legal problem. It means nobody checks for a personal or family history of medullary thyroid cancer, past pancreatitis, pregnancy or medicines that raise the risk of low blood sugar. Those checks exist for a reason. Our guide to getting a semaglutide prescription online explains what a real review looks like.

Salt forms and mystery powders

The FDA says some semaglutide sold by compounders may be a salt form, such as semaglutide sodium or semaglutide acetate. It calls these different active ingredients from the one in approved medicines and says it knows of no lawful basis for using them in compounding.

Also be wary of freeze-dried powder sold for you to mix at home with no pharmacy label, no prescription label with your name and no clear strength. The FDA has received reports, some involving hospital stays, linked to people measuring the wrong dose of injectable semaglutide. A mystery powder with internet mixing directions makes that mistake far more likely.

Before you buy, ask in writing: which form of the medicine is it, which state-licensed pharmacy prepares it, and will the label show your name, the strength and the dose?

Counterfeit pens

The FDA warns that counterfeit Ozempic is being sold in the U.S.. Counterfeit drugs claim to be authentic but may contain the wrong ingredient, the wrong amount or none at all. They are illegal.

Counterfeit risk is highest when brand-name pens are sold below the manufacturer's own price, through marketplaces, social media sellers or "overseas pharmacies." If you want a brand-name pen, the safest sources are a licensed local or mail-order pharmacy filling your prescription, or the manufacturer's own self-pay program.

Ad and checkout tricks

The FTC lists several tactics that show up in weight-loss scams. Expect to see them dressed up for the holidays:

The FDA adds two more: deep discounts that seem too good to be true, and charges for products you never ordered or received.

How to check an offer in five minutes

1. Look for the health questions. A real program asks about your health before you pay for medicine.
2. Find the provider. A licensed provider, licensed in your state, should approve the prescription.
3. Find the pharmacy. Get its name and look up its license on your state board of pharmacy's website.
4. Read the label language. Leave if you see "research use only," "not for human consumption," sodium or acetate.
5. Read the price terms. What is included, whether the price rises with your dose, whether you are charged before approval and whether it auto-renews.

A legitimate program can answer every one of these in plain words. For a deeper version of this checklist, see is cheap semaglutide safe?

What to do if you were scammed

• Do not inject a product you are unsure about. Keep it, with its packaging, in case you need to report it.
• Contact your bank or card issuer to dispute the charge and stop future ones.
• Report the seller to the FTC at ReportFraud.ftc.gov or to your state attorney general.
• Report side effects or a suspect product to the FDA through MedWatch.
• Talk to a licensed provider if you already used it and feel unwell.

Getting treatment through Rx.com

Rx.com offers compounded semaglutide from $99/month and compounded tirzepatide from $149/month on a 12-month plan, with an online provider visit, medication, injection supplies and cold-packed shipping included. It is one flat price at every dose, and no insurance is needed. Nothing is charged until a licensed provider approves you, and plans do not auto-renew.

Now through December 1, 2026, code BF2026 takes 20% off every plan. The 12-month semaglutide plan becomes $950.40 paid up front ($79.20 a month), and the 12-month tirzepatide plan becomes $1,430.40 paid up front ($119.20 a month). See all the Black Friday 2026 GLP-1 pricing.

Compounded medications are not FDA-approved. A licensed U.S. provider decides whether treatment is right for you. Treatment is not available in Alaska, Louisiana or Mississippi. Start with our weight-loss check.

Sources

1. U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026). fda.gov
2. U.S. Food and Drug Administration. BeSafeRx: Considering an online pharmacy? fda.gov
3. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. fda.gov
4. Federal Trade Commission. The truth behind weight loss ads (February 2025). consumer.ftc.gov
5. U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. fda.gov
6. Federal Trade Commission. ReportFraud.ftc.gov. reportfraud.ftc.gov